2015-11-13T10:48:31-06:00 2014-12-31 Grant Thornton LLP 100 E Wisconsin Ave Milwaukee WI 53202 990 2014-01-01 381550001 Michigan Blood % CHARLEEN MELLO MICH 6167742300 PO Box 1704 Grand Rapids MI 495011704 WILLIAM RIETSCHA PRESIDENT/CEO 4142898200 2015-11-12 true Daniel V Romano P00504182 4142898200 2014 2016-04-25 22:37:26Z William Rietscha PO Box 1704 Grand Rapids MI 495011704 51573870 false X www.miblood.org X 1955 MI Helping people make a lifesaving difference through blood products and service excellence 10 9 614 500 0 2098507 2206994 21965633 41106448 15806 726014 -330 1898 24079616 44041354 0 0 0 0 9857339 20625588 0 0 500 11324249 21277136 21181588 41902724 2898028 2138630 32996918 33713554 3429026 4246457 29567892 29467097 X THE PURPOSE OF MICHIGAN BLOOD IS TO PROVIDE A SAFE AND ADEQUATE BLOOD SUPPLY AND BLOOD-RELATED SERVICES FOR THE COMMUNITIES SERVED BY HOSPITAL PARTNERS THROUGHOUT THE STATE. MICHIGAN BLOOD IS THE SOLE PROVIDER OF BLOOD FOR 41 HOSPITAL FACILITIES. THESE HOSPITALS INCLUDE MAJOR MEDICAL CENTERS (SECONDARY- AND TERTIARY-CARE TEACHING FACILITIES) SERVING POPULATIONS TOTALING MORE THAN 2.25 MILLION PEOPLE. THROUGH DONOR CENTERS AND BLOOD DRIVES IN NORTHWEST, EAST-CENTRAL, WEST, AND SOUTHWEST MICHIGAN, MICHIGAN BLOOD RECRUITS AND COLLECTS BLOOD FROM VOLUNTEER DONORS TO ACHIEVE ITS LIFESAVING MISSION. ANNUALLY, MICHIGAN BLOOD COLLECTS APPROXIMATELY 124,000 UNITS OF BLOOD FROM VOLUNTEER BLOOD DONORS AND DISTRIBUTES 238,000 BLOOD COMPONENTS. false false 37077840 0 41106448 For nearly 60 years, Michigan Blood has proudly served Michigan hospitals as an independent, community-based, nonprofit blood center. In addition to blood donation, Michigan Blood administers a variety of key programs and specialty services that further our lifesaving mission. These services include a nationally recognized center for the National Marrow Donor Program, one of only 25 public cord blood banks in America, and we work alongside local hospitals to deliver a number of medical services and therapeutic procedures. Michigan Blood is also affiliated with the Centers for Transfusion and Transplant Medicine, an organization whose members share resources and expertise to improve patient outcomes, as well as conduct leading edge medical research and provide nationwide diagnostic lab services. To learn more about the program services Michigan Blood provides please see detailed descriptions below: Blood Donation: Volunteer Blood donors give blood at nine permanent donor centers throughout Michigan and at blood drives hosted by community organizations and businesses. Each Michigan Blood region also operates a self-contained donor center on wheels. These "Blood Buses" help expand our reach to small communities and urban areas where space is at a premium. See www.miblood.org for a comprehensive list of donation locations. Apheresis: Special equipment makes it possible to collect one or more specific blood components from a donor, while returning the remaining components back to the donor. Apheresis donations allow a greater quantity of one component to be drawn versus a standard whole blood donation. These larger component-specific donations help reduce the number of donors a patient is exposed to, which is preferred by most physicians. Also, patients with diseases such as TTP, kidney rejection, myasthenia gravis, sickle cell disease, or leukemia can be treated by the removal of one or more blood components using therapeutic apheresis technology. Michigan Blood staff and equipment travel to Grand Rapids area hospitals to make this service available as needed. Marrow/Stem Cell Program: In the past 20 years, Michigan Blood Marrow/Stem Cell program has established one of the premier donor-recruitment records in the United States, adding more than 56,000 individuals with advanced tissue typing to the registry of potential stem cell donors maintained by the Be the Match Registry (National Marrow Donor Program). In 2010, the Donor Center received the Donor Management Recognition Award, a lifetime achievement award. The Marrow/Stem Cell Program also provides support services for patients and families seeking compatible stem cell donors. Stem cell transplants remain the primary source of hope for patients with certain kinds of life-threatening diseases. Michigan Blood has helped facilitate lifesaving stem cell transplants for more than 600 people around the world. Cord Blood Bank: Michigan Blood Cord Blood Bank, the first of its kind in Michigan, has collected and stored blood from more than 4,093 umbilical cords. Cord blood is rich in stem cells and cord blood transplantation is finding increasing application in children and adults around the globe suffering from certain life-threatening diseases. Local availability of stem cell collection, processing, storage, and pre-transplant preparation supports the local transplant program's ability to offer advanced medical care. It also offers increased convenience and reduced stress for patients and families who previously had to travel long distances for transplant services. Cellular Therapy: As part of an ever-changing landscape, Michigan Blood supports personalized cellular therapy treatments used in a number of cancers and other life-threatening diseases. For instance, Michigan Blood collects cells from prostate cancer patients to be used in the preparation of personalized treatments. Other applications are routinely being researched and trialed in hopes of gaining FDA approval. The department also collects patient white cells and processes them with UV light to help treat Graft vs. Host Disease and Cutaneous T-cell lymphoma. DNA/HLA Laboratory: This laboratory uses special techniques to conduct tissue typing at the genetic code level to evaluate donor-patient compatibility before transplantation. Local availability of these services helps doctors respond faster to urgent patient needs caused by aggressive diseases. Michigan Blood laboratory services can provide key information in just three to four days; using a distant lab service may mean waiting several weeks for the same data. Patients with transfusion/pregnancy-related sensitivities also benefit from the services of the DNA/HLA Laboratory which helps physicians diagnose, treat and find appropriate blood products. The DNA/HLA Laboratory also types apheresis donors to identify life-saving matches for patients needing component transfusion. Reference Laboratory: Patients with complex transfusion-related sensitivities benefit from the services of the Red Cell Reference Laboratory, which provides information that helps physicians diagnose and treat complicated cases and find rare blood types for transfusion. These patients often are critically ill and may suffer serious complications (including death) without special laboratory services to help their doctors assess the risks of transfusion reactions and donor/recipient incompatibilities. Volunteerism: Michigan Blood offers a wide variety of opportunities for community members interested in volunteering their time to help their community and support Michigan Blood's lifesaving mission. 37077840 true true false true false false false false false false true true false false false true true true false false false false false false true false false false false true false false false false false false false false true false false false false true false false false true 32 0 true 614 true false false false false false true true false false false false X 10 9 false false false false true true true true true false false true true true true true true true true false MI X CHARLEEN MELLO 6162338613 1036 FULLER NE Grand Rapids MI 49503 William J Rietscha President/CEO 40.0 0.0 X X 346043 0 31636 Paul D Smith Secretary/Treasurer 1.3 0.0 X X 0 0 0 Chuck Downey Vice Chair 0.5 1.0 X X 0 0 0 John J Perras Chair 1.3 1.0 X X 0 0 0 Jack O'Donnell Director 0.3 0.0 X 0 0 0 Mitchell G Watt Director 0.3 0.0 X 0 0 0 Linda Constantino Director 0.3 0.0 X 0 0 0 Paul Keep Director 0.3 0.0 X 0 0 0 Derek Bailey Director 0.0 0.0 X 0 0 0 Pat Howe Director 0.0 0.0 X 0 0 0 Charleen C Mello Director of Finance 40.0 0.0 X 98652 0 11781 LeeAnn Wietekamp VP of Quality & Medical Svcs 40.0 0.0 X 315326 0 24788 Mark Palkowski VP of Operations-Thru 10/2014 40.0 0.0 X 261100 0 31126 Tammon Nash Associate Medical Director 40.0 0.0 X 174629 0 17809 Robert Eluskie Director of Info Technology 40.0 0.0 X 109552 0 22033 Maggie Groggel APPLICATION ANALYST 40.0 0.0 X 100911 0 16928 Jen Heraly Dir. of Reg. Compliance/QA 40.0 0.0 X 100578 0 11365 1506791 0 167466 7 false true false 0 24473 2000000 182521 51000 2206994 BLOOD PRODUCTS/TESTING 900099 36474765 36474765 SPECIAL SERVICES 900099 4631683 4631683 41106448 452545 452545 0 0 0 0 0 7780175 8827 7444862 70671 335313 -61844 273469 273469 16026 24473 16933 -907 -907 2855 50 2805 2805 0 0 44041354 41106448 727912 0 0 0 0 1120452 1120452 0 15149621 13339158 1810463 326270 290288 35982 2856477 2502866 353611 1172768 985649 187119 0 10156 10156 55363 55363 3245 1100 2145 0 40590 40590 280562 61544 219018 201836 178208 23628 535914 374684 161230 480528 3200 477328 0 1093737 1091533 2204 376883 366767 10116 0 250806 134640 116166 21164 21164 0 1178883 1085131 93752 249345 229248 20097 BLOOD PROCESSING SUPPLIES 11062665 11062665 BLOOD IMPORT EXPENSE 3434191 3434191 EQUIPMENT & TRANSPORTATION 1323401 1112496 210905 DONOR RECRUITMENT 403886 403886 273981 420586 -147105 500 41902724 37077840 4824384 500 2442071 2903799 0 0 2000020 133467 4059342 3728281 0 0 0 0 0 0 1638565 1427047 328188 521798 27889756 16256921 8524851 11632835 0 0 13655693 13028464 0 0 0 0 348188 337863 32996918 33713554 3429026 2503336 0 0 0 0 0 0 0 0 0 0 0 1743121 0 0 0 0 3429026 4246457 X 27529745 29442451 2027997 14496 10150 10150 29567892 29467097 32996918 33713554 X 2138630 -239425 -2000000 X X false true X true false X 51713 62335 97964 98507 2206994 2517513 37517215 41063808 40481179 21965633 41106448 182134283 0 0 0 37568928 41126143 40579143 22064140 43313442 184651796 0 21435992 22151735 22220741 11144406 20402773 97355647 21435992 22151735 22220741 11144406 20402773 97355647 87296149 435289 276187 319140 268012 452545 1751173 0 435289 276187 319140 268012 452545 1751173 0 18356 18173 20595 10882 18881 86887 38022573 41420503 40918878 22343034 43784868 186489856 0.46810 0.98960 0.00939 0.01000 X Short-Year Return The 2013 Form 990 was a short year with a reporting period of July 1, Public Support Test Calculation The filing organization has made some modifications to methodology for RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false false false false false false false true 3245 3245 false Part II-B, Line 1I Other Activities $1,100 - Assistance with Be The Match license plates for the State of Michigan $2,145 - Assistance with the appropriation from the state of Michigan for marrow typing 2546071 2546071 12552643 7217735 5334908 260928 243769 17159 9786015 6927191 2858824 2744099 1868226 875873 11632835 MUTUAL FUNDS 13028464 F 13028464 0 0 X 43892679 -239425 11923 78827 -148675 44041354 44041354 41993474 11923 78827 90750 41902724 41902724 Schedule D, Part X, Line 2 LIABILITY FOR UNCERTAIN TAX POSITIONS UNDER FIN 48 (ASC 740) The Organization has received a tax determination letter confirming that the Organization qualifies as tax-exempt organizations under Section 501(c)(3) of the Internal Revenue Code (Code). Management believes that there are no material uncertain tax positions that require recognition in the consolidated financial statements. The Organization, while generally exempt from income tax, is subject to tax on income unrelated to their exempt purposes, unless that income is otherwise excluded by the Code. The Organization has not historically filed any unrelated business income tax returns, therefore, tax years remain open for years in which an income tax return has not been filed. The Organization recognizes, if necessary, interest and penalties related to unrecognized tax benefits in the provision for income taxes. There were no interest or penalties related to income taxes that have been accrued or recognized as of and for the year ended December 31, 2014. Schedule D, Part XI, Line 2d Other Changes to Revenue Fundraising Expenses Reported with Revenue $16,983 Loss on Sale of Fixed Assets Reported with Revenue 61,844 ------- Total 78,827 Schedule D, Part XII, Line 2d Other Changes to Expenses Fundraising Expenses Reported with Revenue $16,983 Loss on Sale of Fixed Assets Reported with Revenue 61,844 ------- Total 78,827 Golf Outing 32315 24473 7842 444 193 16246 0 8184 8184 50 40499 24473 16026 444 193 16296 16933 -907 X X X true false false false false false false true false William J Rietscha President/CEO 252027 0 51840 0 42176 0 20763 0 13604 0 380410 0 0 0 LeeAnn Wietekamp VP of Quality & Medical Svcs 260737 0 34023 0 20566 0 18920 0 8599 0 342845 0 0 0 Mark Palkowski VP of Operations-Thru 10/2014 172574 0 11423 0 77103 0 15666 0 20837 0 297603 0 0 0 Tammon Nash Associate Medical Director 165713 0 0 0 8916 0 15854 0 7331 0 197814 0 0 0 Schedule J, Part I, Line 4a Severance Payment An individual left during 2014 and received a severance payment of $36,160. This amount is reported in Schedule J, Part II, Column B(iii). Schedule J, Part I, Line 7 SCHEDULE J, PART I, LINE 7 NON-FIXED PAYMENTS Incentive payout opportunities, based on percentage of base pay rate, are available to certain employees of the filing organization. While levels of the incentive payout opportunity are fixed and determined percentages of base compensation; the incentive payout is subject to the review of accomplishments/ objectives and the ultimate determination of incentive compensation is subject to President / CEO and Executive Committee of the Board approval. X GIFT CARDS 1 51000 FMV false false false FORM 990, PART VI, LINE 6 MEMBERS OR STOCKHOLDERS CENTERS FOR TRANSFUSION AND TRANSPLANT MEDICINE, INC. (A 501(C)(3) ORGANIZATION) IS THE SOLE CORPORATE MEMBER. FORM 990, PART VI, LINES 7A AND 7B MEMBER OR STOCKHOLDER POWERS CENTERS FOR TRANSFUSION AND TRANSPLANT MEDICINE, INC. (A 501(C)(3) ORGANIZATION) HAS RESERVE POWERS, INCLUDING THE ABILITY TO ELECT A MAJORITY OF DIRECTORS. FORM 990, PART VI, LINE 11B FORM 990 REVIEW MICHIGAN BLOOD UTILIZES GRANT THORNTON LLP TO COMPLETE THE IRS FORM 990 AND RELATED SCHEDULES. FOLLOWING COMPLETION, THEY ARE REVIEWED BY THE FINANCE/AUDIT COMMITTEE. THE FULL BOARD IS PROVIDED A COPY OF THE FORM 990 PRIOR TO FILING. FORM 990, PART VI, LINE 12C CONFLICT OF INTEREST POLICY MONITORING & ENFORCEMENT ANNUALLY CONFLICT OF INTEREST STATEMENTS ARE COMPLETED BY ALL BOARD OF DIRECTORS AND KEY MEMBERS OF THE MANAGEMENT TEAM. RESPONSES ARE COMPILED BY THE CENTERS FOR TRANSFUSION AND TRANSPLANT MEDICINE'S LEGAL SERVICES TEAM TO DETERMINE IF ANY CONFLICTS EXIST. IDENTIFIED CONFLICTS ARE ADDRESSED IN ACCORDANCE WITH THE POLICY. FORM 990, PART VI, LINE 15A COMPENSATION DETERMINATION FOR THE CEO A THIRD PARTY EXECUTIVE COMPENSATION CONSULTANT IS ENGAGED ANNUALLY TO ANALYZE AT LEAST FIVE SURVEYS THAT ARE USED TO MAKE UP THE COMPONENTS THAT DEFINE RANGES FOR THE CEO. THE CONSULTANT REVIEWS CURRENT PRACTICE AND ADVISES OUR NEAR TERM APPROACH TO COMPA-RATIO, BASE SALARY INCREASES, AND VARIABLE INCREASES BASED ON A VARIETY OF FACTORS INCLUDING CONTEMPORARY PRACTICES IN HEALTHCARE, BLOODBANKING, AND EVEN BROADER BUSINESS MARKETS. THE HR/COMPENSATION BOARD COMMITTEE REVIEWS MATERIAL FROM THE CONSULTANT. THE COMMITTEE RECOMMENDS COMPENSATION ACTIONS AT THE CEO LEVEL IN THE SUMMER, FOLLOWING THE CONCLUSION OF THE CALENDAR YEAR. CEO COMPENSATION IS APPROVED BY THE BOARD OF DIRECTORS FOLLOWING THE SUMMER HR/COMP MEETING. FORM 990, PART VI, LINE 15B COMPENSATION DETERMINATION FOR OTHER OFFICERS/KEY EMPLOYEES THE THIRD PARTY EXECUTIVE COMPENSATION CONSULTANT IS ENGAGED TO ANALYZE AT LEAST FIVE SURVEYS THAT ARE USED TO MAKE UP THE COMPONENTS THAT DEFINE RANGES FOR THE VP POSITIONS. THE CONSULTANT REVIEWS CURRENT PRACTICE AND ADVISES OUR APPROACH TO COMPA-RATIO, BASE SALARY INCREASES, AND VARIABLE INCREASES BASED ON A VARIETY OF FACTORS INCLUDING CONTEMPORARY PRACTICES IN HEALTHCARE, BLOODBANKING, AND EVEN BROADER MARKETS. THE HR/COMPENSATION BOARD COMMITTEE REVIEWS THE DATA EACH SPRING, AND APPROVES THE DESIGN OF THE VP INCENTIVE COMPENSATION PLAN AT THAT TIME. THE CEO AUTHORIZES VP LEVEL COMPENSATION ACTIONS. THE COMMITTEE VALIDATES THE VP LEVEL COMPENSATION ACTIONS AT THE SUMMER MEETING, FOLLOWING THE CONCLUSION OF THE CALENDAR YEAR. FOR OTHER KEY EMPLOYEES, A SEPARATE COMPENSATION CONSULTANT IS ENGAGED TO PROVIDE MARKET DATA AND RECOMMENDATIONS FOR PAY RANGES FOLLOWING REVIEW OF THE JOB DESCRIPTIONS AGAINST SUCH DATA. FULL MARKET REVIEW THROUGH HUMAN RESOURCES, CEO, AND VP OF TECH OPS OCCURS AT LEAST EVERY THREE YEARS. AD HOC REVIEW OCCURS THROUGH HUMAN RESOURCES STAFF AND CEO AGAINST INDUSTRY AND GEOGRAPHIC SURVEYS HOUSED AT MICHIGAN BLOOD - ABC COMPENSATION SURVEY, MIDWEST COMPDATA SURVEY, AS EXAMPLES. FORM 990, PART VI, LINE 19 DOCUMENTS AVAILABLE TO THE PUBLIC MICHIGAN BLOOD MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C AS IN PRIOR YEARS, THE ORGANIZATION'S FINANCE/AUDIT COMMITTEE IS RESPONSIBLE FOR THE OVERSIGHT OF THE AUDIT. BLOODCENTER OF WISCONSIN INC 638 NORTH 18TH STREET MILWAUKEE WI 532332121 390807235 BLOOD WI 501(C)(3) 07 CTTM INC false BLOODCENTER RESEARCH FOUNDATION INC PO BOX 2178 638 NORTH 18TH STREE MILWAUKEE WI 53201 391372542 SUPPORTING WI 501(C)(3) 11B BloodCenter false CENTERS FOR TRANSFUSION & TRANSPLANT MED PO BOX 2178 638 NORTH 18TH ST MILWAUKEE WI 53201 454675354 SUPPORTING WI 501(C)(3) 11B NA false AURORA AREA BLOOD BANK DBA HEARTLAND 1200 N HIGHLAND AVENUE AURORA IL 60506 362179768 BLOOD IL 501(C)(3) 09 CTTM INC false false false true false false false false false false false false true true false true true false false false